Form D — NewcelX Ltd.
0001213900-25-062768 · filed Jul 10, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- Rule 506(b)
- Reported offering amount
- $1,000,000
- Reported amount sold
- $1,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- NewcelX Ltd.
- CIK
- 1783036
- Entity
- Other
- Jurisdiction
- SWITZERLAND
- Year incorporated
- —
- Address
- HOHSTRASSE 1
KLOTEN, Switzerland 8302 - Phone
- 41 44 512 21 50
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Alexander Zwyer · Executive OfficerZurich, Switzerland Find on LinkedIn ↗
-
Ronald Hafner · DirectorZurich, Switzerland Find on LinkedIn ↗
-
Nicole Fernandez-McGovern · Executive OfficerZurich, Switzerland Find on LinkedIn ↗
-
Florence Allouche Aknin · DirectorZurich, Switzerland Find on LinkedIn ↗
-
Gian-Marco Rinaldi de la Cruz · DirectorZurich, Switzerland Find on LinkedIn ↗
-
Olivier Samuel · DirectorZurich, Switzerland Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗